LGHTvsIBBETF Comparison
VS
Langar Global HealthTech ETF (LGHT) belongs to the Healthcare Technology segment. iShares Biotechnology ETF (IBB) is part of the US Health Care segment. LGHT's top 1 sector exposures are Healthcare. In contrast, IBB's top sector exposures are Healthcare, Non-Corporate and Non-Energy Materials. LGHT is more expensive with a Total Expense Ratio (TER) of 0.85%, versus 0.44% for IBB. LGHT is up 8.98% year-to-date (YTD) with -$1M in YTD flows. IBB performs better with 20.51% YTD performance, and +$516M in YTD flows. Run a side-by-side ETF comparison of LGHT and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
LGHT vs IBB performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/14/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LGHT IBB | +9.71%-0.67% | +27.12%+7.74% | +8.98%+20.51% | +8.87%+34.60% | n/a+67.37% | n/a+30.35% |
| Flows | LGHT IBB | -+$153M | -$86K+$596M | -$1M+$516M | -$2M+$1.72B | --$125M | --$1.20B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LGHT IBB | +37.04%+24.77% | +25.89%+22.23% | n/a+21.33% | n/a+22.50% |
| Max drawdown | LGHT IBB | -8.50%-7.78% | -25.58%-9.61% | n/a-24.82% | n/a-35.62% |
| Max drawdown duration | LGHT IBB | 40d56d | 346d151d | n/a377d | n/a1468d |
Trading data
LGHT | IBB | |
Last sale 10/15/2026 at 1:30 PM | $207.41 | |
| Previous close 10/14/2026 | $203.25 | |
| Consolidated volume 10/14/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
LGHT
is actively managed and doesn’t replicate an indexLGHT | IBB | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/15/2026 at 1:30 PM
Live
Closed
LGHT | IBB | |
|---|---|---|
| Last price | – | $207.41 |
| 1D performance | – | +2.05% |
| AuM | $2.50 M | $10.50 B |
| E/R | 0.85% | 0.44% |
Characteristics
LGHT | IBB | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Langar Investment Management | iShares |
| Benchmark | - | NYSE Biotechnology Index |
| N° of holdings | 30 | 241 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 10, 2024 | February 5, 2001 |
| ESG | Yes | No |
Advertisement
Exposure
Countries
LGHT
USA
83.8%
Other
16.2%
IBB
USA
86.02%
Other
13.98%
Sectors
LGHT
Healthcare
98.54%
Other
1.46%
IBB
Healthcare
99.9%
Other
0.1%
Advertisement
Diversification
LGHT
Total weight of top 15 holdings out of 15
90.56%
IBB
Total weight of top 15 holdings out of 15
56.64%
Top 15 holdings
Data as of August 31, 2026
LGHT
Moderna, Inc.
13.79%
Veeva Systems, Inc.
9.69%
ResMed, Inc.
9.41%
IQVIA Holdings, Inc.
8.20%
Intuitive Surgical, Inc.
7.88%
GE Healthcare Technologies, Inc.
6.77%
DexCom, Inc.
5.92%
Koninklijke Philips NV
4.94%
Siemens Healthineers AG
4.72%
Sonova Holding AG
3.82%
Insulet Corp.
3.61%
Zimmer Biomet Holdings, Inc.
3.21%
Align Technology, Inc.
3.15%
iRhythm Holdings, Inc.
2.91%
Doximity, Inc.
2.54%
IBB
Amgen, Inc.
8.45%
Vertex Pharmaceuticals, Inc.
8.05%
Gilead Sciences, Inc.
7.21%
Regeneron Pharmaceuticals, Inc.
5.72%
argenx SE
3.80%
Moderna, Inc.
3.62%
Natera, Inc.
3.12%
Revolution Medicines, Inc.
2.78%
Illumina, Inc.
2.29%
Alnylam Pharmaceuticals, Inc.
2.27%
Biogen, Inc.
2.25%
BeOne Medicines Ltd.
2.03%
Insmed, Inc.
1.85%
Incyte Corp.
1.73%
United Therapeutics Corp.
1.49%
Frequently asked questions about LGHT and IBB
How have the LGHT and IBB ETFs performed in 2026?
As of October 14, 2026, LGHT is up 8.98% year-to-date (YTD), while IBB has returned 20.51%. That puts IBB better performer ahead so far this year.
Which ETF is attracting more investor money: LGHT or IBB?
Year-to-date, the LGHT ETF saw -$1M in flows, compared to +$516M for IBB.
Which ETF is more volatile: LGHT or IBB?
Over the past year, LGHT had a volatility of 25.89%, while IBB experienced 22.23%.
Which ETF is bigger: LGHT or IBB?
As of October 14, 2026, LGHT holds $2.50 M in assets under management (AUM), while IBB manages $10.50 B.
What sectors do the LGHT and IBB ETFs invest in?
LGHT leans toward sectors like Healthcare. Meanwhile, IBB focuses on Healthcare.
What are the top holdings of the LGHT ETF and IBB ETF?
LGHT top holdings include Moderna, Inc., Veeva Systems, Inc. and ResMed, Inc.. IBB holds in its top three: Amgen, Inc., Vertex Pharmaceuticals, Inc. and Gilead Sciences, Inc..
Which ETF is more diversified: LGHT or IBB?
LGHT holds 30 securities with 90.56% of its assets in the top 15. IBB has 241 securities and a top 15 weight of 56.64%.
Advertisement
Latest news about LGHT & IBB
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
September 18, 2025
IBB
Are Biotechnology ETFs In the Midst of a Comeback?
August 20, 2025
IBB
Investing in the Aging Population: A Look at Bonds and Pharma ETFs
March 27, 2023
IBB
Health is Wealth: A look at the Healthcare Sector
January 24, 2023
IBB
Advertisement
Biotech ETFs – Investing in Health Innovation
July 21, 2022
IBB
Biotech ETFs – Investing in Health Innovation
July 21, 2022
IBB
Advertisement
